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Abstract: Dietary guidelines recommended by key health agencies are generally designed for a global
population. However, ethnicity affects human disease and environment-gene interactions, including
nutrient intake. Historically, isolated human populations with different genetic backgrounds have
adapted to distinct environments with varying food sources. Ethnicity is relevant to the interaction
of food intake with genes and disease susceptibility; yet major health agencies generally do not
recommend food and nutrients codified by population genotypes and their frequencies. In this
paper, we have consolidated published nutrigenetic variants and examine their frequencies in
human superpopulations to prioritize these variants for future investigation of population-specific
genotype-directed nutrition. The nutrients consumed by individuals interact with their genome and
may alter disease risk. Herein, we searched the literature, designed a data model, and manually
curated hundreds of papers. The resulting database houses 101 variants that reached significance
(p < 0.05), from 35 population studies. Nutrigenetic variants associated with modified nutrient intake
have the potential to reduce the risk of colorectal cancer, obesity, metabolic syndrome, type 2 diabetes,
and several other diseases. Since many nutrigenetic studies have identified a major variant in some
populations, we suggest that superpopulation-specific genotype-directed nutrition modifications
be prioritized for future study and evaluation. Genotype-directed nutrition approaches to dietary
modification have the potential to reduce disease risk in select human populations.
Keywords: nutrigenetics; gene-diet interaction; nutrient; superpopulation; SNP
1. Introduction
As genomics holds promise to transform global health and medicine, there is a growing interest
in the relationship between genotype and phenotype. Phenotype is derived from both genetic and
environmental contributions. The most common environmental influences on phenotype are direct
exposure to pathogens and nutrient intake. Herein, we focus on human nutrigenetics. Food-based
dietary guidelines are periodically developed by global organizations, especially the Food and
Agricultural Organization (FAO) of the United Nations and World Health Organization (WHO). These
organizations play a vital role in shaping food policies and guidelines globally, considering unique
cultures, food availability, eating habits, food safety, and other factors for each country.
There is mounting evidence that human behavior of diet selection is hereditary. Measurements of
heritability separate the genetic and environmental components of any disease or trait. Approximately
Int. J. Mol. Sci. 2019, 20, 3516; doi:10.3390/ijms20143516 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 3516 2 of 15
60%–80% of the variability in human height is genetically derived with 20%–40% coming from the
environment [1]. The heritability is higher in developed countries and lower in developing countries,
inferring that the environmental differences are nutrition-based. Consistent with these estimates,
the general heritability of food intake patterns is 27%–32% [2]. Other more focused studies impart
further support. The heritability of food intake in the Chinese population ranges from 19%–95%
depending on types of food and gender [3]. A 12%–24% heritability of eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) consumption was identified by a meta-analysis of 17 cohorts [4,5].
The heritability of choosing bread as a food source in Danish and Finnish cohorts ranges from
23%–45% [6].
Once a genetic component of a trait or disease is identified, the next challenge is to decode the
genetic variation that explains the heritability, focusing most often on the contributions of individual
genes and alleles and more recently on epigenetic changes. This has not yet been well-characterized for
human dietary patterns. Very little is known about nutrigenetic variants that affect disease in different
populations. Polymorphisms in several genes associated with folate and alcohol consumption, and
colon cancer risk have different frequencies in Caucasians and African Americans [7]. There are ethnic
effects on plasma polyunsaturated fatty acid levels and preferences for plant protein consumption [8,9].
Although not associated with disease, a principal component analysis identified dietary-driven
differences in high abundance plasma proteins among ethnic groups [10]. This study identifies
published nutrigenetic variants that have large genotypic differences in different superpopulations [10].
There are new opportunities to explore the role of genetics in the human diet that are supported
by strong evidence. The recently reduced cost of sequencing a human genome, exome, microarrays,
and genotyping has advanced the understanding of human genetic variation. Variants from >2400
genome-wide association studies (GWAS) consolidated in the GWAS catalog contain over 100,000
disease- or trait-associated variants for rare and common disease with a p < 10−5 [11,12]. A small
number of these variants have clinical utility for disease diagnosis, prognosis, or treatment.
The strong interactions between gene, diet, and disease first became apparent in the 1930s with
the identification of phenylketonuria (PKU), a prototypical rare Mendelian disorder characterized by
mutations in PAH and a deficiency in phenylalanine metabolism [13,14]. In individuals with PKU, the
buildup of phenylalanine derived from the diet becomes toxic and lethal [15]. Starting after birth, the
major approach to lifelong treatment is a modified diet with low levels of phenylalanine [16]. This
clinical nutrition therapy is similar to other nutrition therapies for the treatment of galactosemia and
hereditary fructose intolerance [17,18].
Over the past two decades, advances in GWASs and studies with focused candidate gene panels
have enabled scientists to more rapidly identify genetic variants in gene-diet interactions and their
associations with disease. This new capability has driven the emergence of the field of nutrigenetics [19].
Nutrigenetics assesses how a person responds to specific nutrients based on the variation within
their genome. Many studies and trials have identified nutrigenetic variants associated with common
diseases such as colorectal cancer, obesity, type 2 diabetes, and cardiovascular disease to name a
few [20–23].
The number of publications in nutrigenetics has steadily increased over the past 17 years
(Figure 1). Despite a significant amount of research in this field, the data have not been
systematized into an accepted model to assess a person’s genetics acquired by panel genotyping, single
nucleotide polymorphism (SNP) microarrays, whole-exome sequencing, or whole-genome sequencing.
The nutrigenetics.net database is a public collection of nutrigenetics literature. Most of the SNPs related
to nutrigenetics are not present in other structured databases such as ClinVar, LOVD, and HGMD.
These structured databases hold limited nutrigenetic data, but house clinical SNPs, disease-associated
SNPs, and human genetic variation data related to traits and behavior [24–27].
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variant frequencies in global superpopulations. Genotype-directed nutrition was previously defined 
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provide significant health benefits. We do not know of another report that globally prioritizes 
nutrigenetic studies for validation studies based upon SNP frequency. Note, that this effort is focused 
on diets for normal people, and not for clinical nutrient therapies, which are medical treatments and 
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Figure 1. Bar graph of the nutrigenetics publication trend. The bar graph shows the number of
nutrigenetic publications per year, beginning in 2001. The total number of papers is 2,317. Abstracts
were identified by querying PubMed, with terms related to nutrigenetics and disease. Examples are
indicated in the Materials and Methods section.
Several nutrigenetic companies have emerged with goals of prescribing food intake and exercise
with genetics. These companies offer clients genotyping, and/or secondary data analysis. The results
are then processed to suggest personalized nutritional modification strategies. However, this new field
is not without controversy with some criticism of nutrigenetic testing companies [28–30]. However,
others have pointed out that some of the criticisms are not factually based and are potentially damaging
to private interests [31,32]. Thus, the challenge remains to improve upon and disclose the value of
genetic testing procedures based on quality scientific evidence.
The main goal of this study is to prioritize SNPs for validation of genotype-directed nutrition
dietary modifications to reduce the burden of disease risk in healthy people based upon genetic variant
frequencies in global superpopulations. Genotype-directed nutrition was previously defined and
the five major superpopulations are as defined in the 1000 genomes project [33,34]. Herein, the term
“genotype-directed nutrition” reflects dietary modifications based upon common nutrigenetic variants
with high frequencies in at least one human population. This is in contrast to personalized nutrition,
where the diet is precisely designed for each individual and not a population. The proposed population
stratification and genotype-directed nutrition could be further tested and if validated provide significant
health benefits. We do not know of another report that globally prioritizes nutrigenetic studies for
validation studies based upon SNP frequency. Note, that this effort is focused on diets for normal
people, and not for clinical nutrient therapies, which are medical treatments and should be subject to
stricter clinical validation studies.
2. Results
2.1. Literature Annotation for Nutrigenetic Database
The first step needed for creating genetic-driven nutrition modification was to create a
nutrigenet c database xtracting information from published articles into structured data. There
were ~2,300 nutrigen tics articles published since 2001 (Figure 1). A database was built from published
studies employing well-defined criteria for variant selection following the process schema diagram in
Figur 2.
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Figure 2. Nutrigenetic paper annotation workflow.
We evaluated each article for quality based on reported odds-ratios and p-values and optional
confidence intervals. Any nutrigenetics study reporting a p-value (p < 0.05) was considered for further
annotation [35]. Any GWAS was considered if it met the p < 5 × 10−8 threshold for genome-wide
significance, which incorporates the Bonferroni correction for multiple testing. An annotation entry
also required reported log odds ratio (0.97 < OR > 1.03) for an association between a nutrient and a
disease or endophenotype outcome. We selected articles that had a log-odds ratio for the disease or
endophenotype and also for the effect of the nutrient intake and variant on the disease risk. Protective
or risk factor variants had odds ratios for gene-diet interactions greater than that of the nutrigenetic
population and vice-versa for a protective variant. Since confidence intervals are not always represented
in articles, and while useful, they are not essential to the annotation process, thus can be entered as
null in the database.
Articles meeting these criteria were next cross-referenced with MedGen, Online Mendelian
Inheritance of Man (OMIM), and ClinVar. If the variant did not have a dbSNP identifier, one was
obtained from SNPedia. If C. notation for the variant was not available, the information was obtained
with Mutalyzer. The PubMed identifier was also recorded.
Int. J. Mol. Sci. 2019, 20, 3516 5 of 15
2.2. Summary Statistics for Nutrigenetic Variants
The current database version has 156 gene-diet interactions with 101 unique variants in 84 genes
passing the annotation quality criteria (Table 1). These variants account 145 nutrient intake or dietary
suggestions, resulting in 290 total entries. Multiple entries can come from a study due to multiple
variants reaching significance or multiple diet groups accompanying a particular variant within the
same study. This set of variants accounted for the risk of 38 phenotypes, most of which were diseases,
although some constitute endophenotypes. The ORs ranged from 0.07 to 35 with most SNPs (67%)
increasing risk for the phenotype.
Table 1. Statistics for construction of the nutrigenetic database.
Category 2Number
Articles 67
Annotations 156
Phenotypes 36
Genes 84
1SNPs 101
Protective 52
Risk 104
1OR range (Avg) 0.07–35 (2.17)
P-value range (Avg) 3.5 × 10−5 – 0.05 (0.018)
Diet types 106
Participants range (Avg) 1–16,624 (1106)
Note: 1 Abbreviations are: SNP = single nucleotide polymorphism; OR = Odds ratio; Avg = average; 2 Numbers in
parentheses are averages.
An example disease, colorectal cancer, is associated with 23 unique variants and affected by 34
different gene-nutrient interactions. The majority of the variants correlate with an increased risk of
disease, which can be mitigated by nutrient intake. Folate was consistently identified in many gene-diet
interactions, increasing or lowering disease risk dependent upon the amount ingested. A cohort study
examining colorectal cancer identified gene-diet interaction between the MTHFR gene and folate intake
in Koreans. Carriers of the C base in the C677T SNP variant had a decreased risk with high intake
of folate (>282 µg/d: OR 0.62, p < 0.002, confidence interval [CI] 95%: 0.46–0.84) [36]. This is just
one example disease where evidenced-based modifications to a person’s diet could ameliorate the
increased risk of disease [36].
2.3. Genotype-Directed Nutrition Prioritization for Superpopulations Based on Nutrigenetic Variants
Studies of gene–diet interactions are designed to generally identify common variants in the
population that have detectable effects from prevalent SNPs. Thus, it is no surprise that our nutrigenetics
database has 37% of nutrigenetic SNPs with global SNP frequencies for nutrigenetic variants >50%,
with all variants having a wide range of frequencies (Figure 3). Furthermore, of the 101 unique variants,
six had global SNP frequencies >90%. We reasoned that these variants could be utilized to improve
population health. Therefore, we further examined how SNP frequencies of these variants varied among
superpopulations (Africans, Americans, East Asians, Europeans, and South Asians) by analyzing the
1,000 genomes phase 3 data. There were 17 SNPs where comparison of two superpopulation had an
FST > 0.5, with values ranging up to 0.71.
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An example in Table 2 shows that a variant in the VDR gene is much less frequent in Africans
with the FST for all superpopulations ranging from 0.06 to 0.71. We, therefore, examined those variants
with SNP frequencies of above 50% in at least one superpopulation (Table 2).
Studies on these SNPs suggest nutritional changes for the superpopulations that may have a
population-wide benefit for the diseases associated with these variants. For all populations, low fat,
high n-3 PUFA, low n–6 fatty acids, and high folate may reduce the global disease risk for five common
disorders (Table 3). While high n–6 fatty acids are a general suggestion, people with this genetic variant
might consider low n–6 fatty acids in their diets [38]. There are also several superpopulation specific
suggestions. For example, low calcium (<680 mg/day), low alcohol and high Vitamin D consumption
for East Asians may be a dietary means to reduce population incidence of prostate cancer and obesity.
This may require stratification by subgroups as addressed in the discussion section.
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Table 2. Frequencies for select SNPs with >50% population difference.
2dbSNP ID Gene Disease Dietary Change
1,2,3Superpopulation SNP Frequency
ALL AFR AMR EAS EUR SAS
rs9997745 ACSL1 Metabolic Syndrome
1Low-fat (<35% energy),
high-PUFA diet (>5.5% energy)
78 40 87 100 85 93
rs6008259 PPARA Hypercholesterolemia Low n–6 fatty Acid (≤7.99 g/day) 73 86 24 100 82 92
rs6087990 DNMT3B Colorectal Cancer 1,4High RBC folate 68 76 63 92 37 68
rs3790433 LEPR Metabolic Syndrome 1,5Low n-6 PUFA, high n-3 PUFA 59 23 67 84 77 58
rs11568820 VDR Prostate Cancer Low calcium (<680 mg/day) 54 11 82 60 77 64
rs512535 APOB Metabolic Syndrome Low fat (<35% energy) 53 19 51 81 51 73
rs10495563 ADAM17 Obesity 6Low n-6 fatty Acid 52 30 56 90 34 58
rs2287161 CRY1 Metabolic Syndrome Low carbohydrate (% of energyintake <41.7%) 46 64 52 13 45 54
rs3827730 FAF1 Alcohol Dependence 7Low amounts of alcohol 38 7 52 79 35 28
rs2424913 DNMT3B Adenoma, ColorectalCancer No alcohol 31 33 36 1 59 29
rs1801181 CBS Colorectal Cancer 1,4High RBC folate 30 2 19 57 39 36
rs2424909 DNMT3B Colorectal Cancer Moderate alcohol >0 and <1.7drinks/week 28 8 36 8 63 31
rs1378942 CSK Hypertension 11.8 g/day of EPA and DHA 24 3 33 18 61 16
rs2168784 (Intergenic) Alcohol dependence no alcoholic drinks/week 24 62 10 9 10 13
rs1229984 ADH1B Alcohol dependence no alcoholic drinks/week 16 0 6 70 3 2
rs75038630 NADSYN1 Abnormal EatingBehavior High vitamin D (>75 nmol/L) 2 0 4 100 6 3
Note: 1 Abbreviations are as in Table 1 and: PUFA = polyunsaturated fatty acid; RBC = red blood cell; EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid; g= gram; mg = milligram;
L = liter; population abbreviations are defined in text. 2 SNPs with FST > 0.5 for two superpopulations. 3 SNPs with a >50% frequency are shaded gray. 4 Low levels of RBC folate is
defined as (<484 ng/mL) and associated with a risk, therefore, high levels of folate consumption should offset this risk and are reported as high RBC folate. 5 Low PUFA status (<45.85% of
total measured fatty acids) if the diet is low (less than the median) plasma n-3 and high (n-6) PUFA. 6 Undefined amount in the article. 7 Dietary change: non-alcohol dependence or low
occurrence of drinking alcohol.
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Table 3. Nutrigenetic dietary suggestions for superpopulations.
Category 1Diseases 1,2Dietary Suggestion
All
Metabolic Syndrome,
Hypercholesterolemia, Colorectal
Cancer, Prostate Cancer, Obesity
Low-fat (<35% energy), High-PUFA diet (>5.5%
energy), Low n–6 Fatty Acid (≤7.99 g/day), Low
Calcium (<680 mg/day)
AFR Hypercholesterolemia, Alcoholdependence
Low n–6 Fatty Acid (≤7.99 g/day), 0 alcoholic
drinks/week
AMR Colorectal Cancer, Prostate Cancer,Obesity, Alcohol Dependence
High PUFA, Low Calcium (<680 mg/day), 3Low
n-6 Fatty Acid
EAS
Hypercholesterolemia, Prostate
Cancer, Obesity, Alcohol Dependence,
Abnormal Eating Behavior
Low n–6 Fatty Acid (≤7.99 g/day), Low Calcium
(<680 mg/day), 3Low n-6 Fatty Acid, High
vitamin D (>75 nmol/L)
EUR Hypercholesterolemia, ProstateCancer, Adenoma, Hypertension
Low n–6 Fatty Acid (≤7.99 g/day), Low Calcium
(<680 mg/day), 1.8 g/day of EPA and DHA
SAS Hypercholesterolemia, ProstateCancer, Obesity
Low n–6 Fatty Acid (≤7.99 g/day), Low Calcium
(<680 mg/day), 3Low n-6 Fatty Acid
Note: 1 Table 3 is a summary of information from Table 2. 2 Abbreviations are as in Tables 1 and 2. 3 Undefined
amount in the article.
3. Discussion
The human condition is not just affected by genes, as many traits and conditions are also affected
by physical location, environmental exposure, exercise, microbial interactions, and diet. Two prospects
are information and genetic-driven, personalized medicine and prevention. While there are several
approaches to prevention, in this article, we focus on genetic-driven food and nutrient intake as a source
of prevention in the emerging field of nutrigenetics. Food is an important daily exposure factor that
provides a wide variety of nutrients, non-nutrients, and even chemical contaminants that can modulate
disease risks. For most human diseases, the risk is a combination of heritability, environmental factors
from nutrient intake, and gene-diet interactions.
With the recent advances in commercialization of recreational genetics and further development
of genetic investigations, there is a recent re-emergence of nutrigenetics companies. We considered
the qualities of implementing scalable nutrigenetics that are needed for successful implementation.
In this paper, we expand on three that we think are important, variant quality, collection of nutrigenetic
data into a structured database, and how this information can be leveraged to prioritize studies for
population-specific diets.
3.1. Variant Quality
Variant quality is a concern for several reasons that became more apparent as we annotated variants
from the literature. Upon completion of our variant annotation database, the Global Nutrigenetics
Knowledge Network (GNKN) reported standards for the quality and utility of nutrigenetic variants [29].
Many nutrigenetic research studies do not reach the rigor of the draft of standards proposed by the
GNKN. Therefore, we revised the goal of this study to compile and analyze existing nutrigenetic
studies to prioritize variants for validation studies. We had independently used a p < 0.05 corrected for
multiple testing criteria, a log odds ratio with a significant change, and confidence intervals.
There are several guidelines (STEGA, EGAPP, and GRADE) for clinical validity and utility of
genetic tests [29,39–41]. For the current state of knowledge and difficulties in nutrigenetic studies, the
clinical stringent criteria are generally too strict. They are designed for medical care, where errors
in treatment could have life-threatening or life-altering effects. We emphasize that the purpose of
our genotype-directed nutrition study is to prioritize variants to reduce disease susceptibility risk of
healthy people with preventative or early detection strategies and not for clinical medicine.
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Some additional GNKN guidelines will be useful for classification of nutrigenetic variants.
In particular, our variants should be further characterized for the hierarchical level of evidence
supporting the variant marker, as well as the magnitude of effect as suggested by EGAPP [39].
The European Food Safety Authority (EFSA) scientific validity guideline is based on a number
of studies, rather than a statistical outcome from a meta-analysis, which has a stronger scientific
rationale [29]. The framework does not include a model to classify more complex metrics of genetic
architecture such as genetic and polygenic risk scores. These metrics are geared toward susceptibility,
which in general explain more of the heritability for common traits, conditions, and behaviors such as
nutrient intake. These metrics are better suited to evaluate risk and are becoming rapidly accepted as
approaches of choice for susceptibility to common disease [42–44].
These criteria fit that of a rare variant, rather than a common variant. Given the generally low
number of participants in nutrigenetics studies when compared to large clinical trials, it is difficult
to identify rare variants that have large effects as is the case for Mendelian disorders. In fact, this is
the claim of the blood group diet where there are alleles of large effect, but these blood type alleles
are not rare. Nevertheless, rare variants are of limited utility for genotype-directed nutrition in
large populations unless many are identified. Currently, there are only a few examples reported for
Mendelian disorders, as exemplified earlier by mutations in the PAH gene and clinical treatment of
patients afflicted with PKU by dietary therapy [16,45].
In general, the 1,000s of new GWAS studies over the past decade support a model for a common
disease where there are many common variants of small effect sizes, perhaps triggered by a specific
combination with a rare variant. A more common recent practice is to sum the smaller risk of these
large sets of common variants associated with any affliction into a genetic or polygenic risk score. This
better models the polygenic and heterotypic nature of common disease. The effect of food intake on
common disease is more likely to resemble a common disease, thus may be better approached by
genetic risk scores. However, the field of nutrigenetics is yet to adopt this approach. This is a limitation
that will need to be addressed in the future and modeled in current guidelines.
3.2. Nutrigenetics Database
Nevertheless, within the context of these limitations, we sought a way in which we could
take advantage of the growing number of nutrigenetics studies. There are well-developed nutrient
databases, but no comprehensive nutrigenetics databases [46]. We developed a data model to capture
critical nutrigenetic information and annotated ~156 gene-diet interactions from a comprehensive
review of the nutrigenetics literature. While all studies were statistically significant, we recognize that
for most of them, the study size is of small by today’s standards, may not have been repeated, and
therefore, some results may not repeat in a larger study or a meta-analysis. Furthermore, compliance
with nutrient intake may be challenging in these studies. One particular challenge was modeling
ethnicity, epistasis and the broader applicability of variants identified in a study focused on a specific
ethnic population. Nevertheless, the value of our nutrigenetics database is synergistic with other
nutrition-related databases that are publicly available such as the U.S. Department of Agriculture
(USDA) nutrient database and PhenolExplorer for phenol content in foods [47].
3.3. Genotype-Directed Nutrition for Populations
Many genetic studies focus on specific ethnic populations, or pedigrees to isolate variants from
variable genetic backgrounds. Even though ~100 nutrigenetic variants met our quality stringency
criteria for annotation, the knowledge gained from these genetic studies is not yet used in the design
of population-specific diets. To explore whether this information could potentially be useful for
adjusting diet design, we examined FST values for human populations. A small group of the SNPs were
common in all populations, while a larger subset had significant changes in SNP frequencies between
populations. Since the gene-diet interaction SNP was the major SNP in one or more superpopulation
this information could be used to suggest superpopulation-specific nutritional changes when compared
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to a recommended diet. The summation of this approach yielded a collection of nutrition suggestions
for each superpopulation, which can be further tested for validation. Other aspects of nutrigenetics,
such as ethics, food supply, and food safety would also need to be considered.
3.4. Limitations
While the potential of a nutrigenetic precision diet is an attractive and intuitive concept in the
prevention and management of chronic diseases, there are several limitations that must be considered
in the interpretation of these data.
We recognize that variant interpretation may be more complex as the gene-diet interactions may be
more polygenic in nature, like common diseases. In this case, a genetic risk score may be more suitable
than SNPs associations. Indeed, the problematic nature of using single SNPs to predict complex traits
are well known [48]. Most current nutrigenetics studies are limited examining small population sizes
and a portion of these studies may not repeat upon a more rigorous design. However, we are using
these studies for prevention and not for clinical intervention, thus the bar for quality does not have to
be as high. Nevertheless, ideally, validation studies on larger populations should be tested prior to
implementing a nutrigenetic recommendation. There are also instances where different nutrigenetic
variants may influence the same phenotype and dietary associations [22,49]. However, genetic risk
may be better predicted at the group level, as suggested in this paper, rather than for individualized
predictions [48].
The majority of nutrigenetic studies differ in study design, population demographics, and sample
size, thus introducing bias. The SNPs identified from one ethnic group may not be more broadly
generalizable to other populations due to epistasis. Many of these studies must be replicated in
other population types since genetic variation across ancestries and geographical regions exist [50].
Furthermore, with the recent ease and frequency of human migration, the superpopulation dietary
suggestions are based on SNP frequency, which is not applicable to ‘interracial’ populations. Potential
solutions are to derive dietary suggestions from an individual superpopulation(s) of ancestral origin or
to analyze an individual’s genetic file.
Another limitation in the current field of nutrigenetics is research factors in the design of studies
that identify variants. This includes the type of study design (e.g., meta-analysis, randomized
trial, longitudinal, prospective, cross-sectional). Other characteristics such as outcome, effect size,
population size, control groups, and confirmation by a separate research study should also be considered.
Furthermore, conclusions drawn from a study with “significant” p-values are under scientific scrutiny
and should also include effect sizes, Bayesian measures, and reproducibility with meta-analyses from
multiple studies [51]. Certainly, our database is limited by the qualities of available studies and that is
why we suggest that the data we collected and modeled be used primarily to prioritize hypotheses for
future investigation.
Population-level dietary recommendation is standard practice and we propose that
genotype-directed nutrition for genotypes with high frequencies in populations could provide
significant health care savings and reduce morbidity and loss of productivity. However, another key
consideration is that some nutrient suggestion may need to be codified for specific groups within the
population. For example, nutrigenetic variant suggesting low calcium intake (<680 mg/dL) for healthy
adults needs to be carefully considered for specific population groups such as infants, adolescents,
pregnant women, postmenopausal women and the elder population where this suggestion may not be
applicable or even harmful.
4. Material and Methods
4.1. Data Sources for Nutrigenetic Variants
The majority of nutrigenetics knowledge exists in free form text of peer-reviewed publications.
Due to current limitations in interpretation and mining information out of the free-form text, we decided
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to adopt manual annotation, which, while more time consuming, has the advantage of better accuracy.
We reviewed the current scientific literature regarding dietary nutrients and nutrigenetic variants.
The PubMed database was queried with keywords and phrases to collect relevant nutrigenetic
articles. Examples of such query phrases included, but were not limited to, “nutrigenetic”, “gene-diet
interaction”, “diet intake”, “polymorphism”, “consumption”, and “nutrient intake and gene-diet
interaction”. We also searched for combinations of these keywords and queries where “diet” was
replaced with “food source”, “nutrient” or “mineral”. These search queries required multiple variations
to find the relevant articles for annotation. A second major source of nutrigenetic variants was the
GWAS catalog [11,12].
Information in the primary literature or GWAS catalog was extracted into a nutrigenetic data
model (see Results). Variants were cross-referenced to National Center for Biotechnology Information
(NCBI) data such as the PubMed, Entrez Gene, and MedGen databases where applicable. Entrez
Gene and GeneCards were sources of gene summaries. Diseases were referenced with OMIM. dbSNP
provides SNP IDs for each variant, and for cross-reference with several other databases such as the
1000 Genomes Project.
All variants were entered with HGVS notation. For the c, p, and g fields, c. is the nucleotide
position in the gene, p. is the position of the amino acid substitution in the gene, and g. is the nucleotide
position within the entire chromosome. The reference genome for the database is GRCh37.p13.
Although there are newer reference genomes, data that were included from several other databases
and websites were referenced against GRCh37.p13. The USDA nutrient database provided a source of
nutrients in foods [46].
4.2. Population Frequencies and FST Values of Nutrigenetic Variants
The frequencies for each SNP variant were retrieved from the 1000 Genomes Project, phase 3
browser running Ensembl version 80, and referenced against GRCh37. The 1000 Genomes Project,
phase 3 utilizes more than 80 M short variants with genotypes of 2504 individuals across 26 global
populations [37]. The human superpopulations are all, African (AFR), Admixed American (AMR), East
Asian (EAS), European (EUR), South Asian (SAS). SNP frequency data for human superpopulations
were from the 1000 genomes project. The fixation index (FST) values for pairs of superpopulations were
calculated from SNP frequency data with Excel. FST is calculated from the equation: FST = σ2S/σ2T
where σ2S is the variance in the subpopulation and σ2T is the variance in the total population. These
values measure the differences in frequencies of the SNPs across subpopulations.
4.3. Data Model
Nutrigenetics variant data annotated from the literature, NCBI databases, and the USDA nutrient
data was modeled in a MySQL database. The database has six tables (Figure 4). These include a user
table (“User”) (with an anonymized user ID), a table linking each user to the relevant nutrigenetic
variant entries (“UserEntry”), the genetic variant table (“NutrigeneticsEntry”), a genotype table
(“Genotype”), a dietary suggestion table, and a table with foods and nutrients relevant to the entries on
the suggestion table (“FoodOrNutrient”). The “NutrigeneticsEntry” table contains general information
about the database variants with gene summaries, the dbSNP ID, phenotype, and chromosomal
position. Each entry in the “NutrigeneticsEntry” table corresponds to one or more entries in the
“Genotype” table. These entries include information on the effected minor frequency SNPs, including
SNPs and p-values, odds ratios, and confidence intervals for the variant-disease interaction.
Each entry in the “Genotype” table is associated with entries in the “foods and nutrients” table.
This table contains information on each dietary suggestion, such as the suggestion type (which
may be to consume a certain portion of a food, nutrient, or food group, or to monitor a particular
endophenotype), PubMed ID, study description, population risk data, and the p-value, OR, and CIs
for the variant-phenotype-diet interaction for the suggestion. Each “foods and nutrients” entry is, in
turn, associated with multiple entries on the “FoodOrNutrient” table. This table contains the relevant
Int. J. Mol. Sci. 2019, 20, 3516 12 of 15
USDA nutrient database information for the suggested foods, such as the number of servings needed
to provide the suggested daily value of a nutrient and the food’s nutrient content.
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5. Conclusions
1. Nutrigenetic variants with high superpopulation frequencies can be used to prioritize dietary
modifications for the purpose of reducing disease risk for human superpopulations with the
potenti l for widespread health benefit .
2. The proposed superpopulation genotype-directed nutrition modifications will need to be validated
in a research stu y.
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